Aldena Therapeutics is a subsidiary of Alys Pharmaceuticals that focuses on developing siRNA-based treatments for skin conditions.

Aldena Therapeutics

Aldena Therapeutics develops innovative therapies for Dermatology: changing the paradigm by discovering and enabling delivery of nucleic acid therapies in conditions with high burden to patients

Innosuisse

Medicxi

The entire team at Aldena is thrilled to become an integral part of Alys Pharmaceuticals !

Nature Comms features one of Aldena's lead assets  !
Read here: https://rdcu.be/dqorR about the great collaboration between UMass's all star teams of Anastasia Khvorova, Craig Mello and John E. Harris, MD, PhD and Aldena Therapeutics

ALDE

COM:ALDENATHERAPEUTICS

Aldena Therapeutics

locale

market

industry

website

linkedin

founding date

investor of

Metrics